Advertisement Fidelity
Home > Boards > US OTC > Biotechs >

Galectin Therapeutics Inc. (GALT)

Add GALT Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator 123tom
Search This Board:
Last Post: 4/22/2014 9:58:25 PM - Followers: 35 - Board type: Free - Posts Today: 0

 We are a development-stage company engaged in the discovery, development, and commercialization of first-in-class, targeted therapeutic compounds for advanced treatment of cancer, liver, microbial and inflammatory diseases. Our initial focus is the development of a new generation of anti-cancer treatments using carbohydrate polymers to increase survival and improve the quality of life for cancer patients. We believe that the need to improve drug therapies, particularly anti-cancer agents, is significant and represents a large market opportunity.

DAVANAT®, our lead pipeline candidate, is a proprietary chemical entity that is currently in Phase II trials for first-line treatment of colorectal and biliary cancer. Our targeted therapeutic compounds can also be used to treat other serious diseases, such as liver and kidney fibrosis. We have entered into research collaborations with the Mt. Sinai School of Medicine in New York to study the anti-fibrotic effects of the Company’s novel carbohydrate compounds on liver fibrosis; with the Brigham and Women’s Hospital in Boston to evaluate the anti-fibrotic effects of these compounds to treat acute and chronic kidney disease; and with the University of California at Davis and Fudan University in Shanghai to conduct anti-fibrosis tests. In animal models, our compounds have shown to significantly reduce collagen expression and reverse fibrosis. Whereas previous in vitro data has only indicated a reversal of fibrosis markers, in proof-of-concept animal studies during October 2007, the compounds significantly reduced collagen expression and reversed liver fibrosis.

Recent News:

Research Collaboration with Dr. Scott Friedman and Mt. Sinai Hospital:

Patent for Galectins extended to Australia:

PRWP Receives $489,000 in Grants for Galectin Research:

PRWP Ships First Commercial Order for Davanat in Columbia:

#653  Sticky Note For those interested in the science of the Darwinian 03/14/14 05:57:24 PM
#897   Biotech2010, let me respond to your criticism. 123tom 04/22/14 09:58:25 PM
#896   OCA has to be taken daily over a thefamilyman 04/22/14 09:26:10 PM
#895   I agree that Cohort 2 results will be biotech2010 04/22/14 05:20:37 PM
#894   Darwinian: I agree with you that OCA Tesla1 04/22/14 05:10:08 PM
#893   Tesla said: Darwinian 04/22/14 04:50:45 PM
#892   Chess: Based on cohort 1 and reading the Tesla1 04/22/14 04:44:38 PM
#891   You should stop giving yourself credit for accuracy biotech2010 04/22/14 04:23:48 PM
#890   CM, I think that's a great summary of 123tom 04/22/14 03:29:16 PM
#889   I agree. News always trumps charts. tradervader 04/22/14 03:08:02 PM
#888   I think you are overanalyzing things and thus Chess Master 04/22/14 12:04:25 PM
#887   I try and use both. Charts need catalysts... tradervader 04/21/14 09:44:18 PM
#886   I would look to buy any real buys tradervader 04/21/14 09:43:40 PM
#885   I think the fundamental story for GALT is 123tom 04/21/14 09:36:22 PM
#884   yes, that's what I think too, but the 123tom 04/21/14 09:31:31 PM
#883   Nice buys. I just wanted to make sure tradervader 04/21/14 09:27:57 PM
#882   Yea, I've stayed out of them the past tradervader 04/21/14 09:24:39 PM
#881   The weekly 50 ma is at 9.38 now 123tom 04/21/14 09:21:08 PM
#880   11.40. Last time it broke the 200 tradervader 04/21/14 09:17:02 PM
#879   wow...10k... that's impressive. didn't you buy at the 10 123tom 04/21/14 09:13:31 PM
#878   All very good points to consider. I tradervader 04/21/14 09:10:24 PM
#877   How about if the greater market turns 123tom 04/21/14 09:06:37 PM
#876   Thanks, I appreciate it. I see what tradervader 04/21/14 08:36:25 PM
#875   Tradervader, I do see what you looked at 123tom 04/21/14 08:29:10 PM
#874   Didn't the head and shoulders already complete itself tradervader 04/21/14 07:44:54 PM
#873   Yes yes,the 200 ma I mentioned that feature 123tom 04/21/14 07:19:01 PM
#872   Bought 1000 more shares today. Look at tradervader 04/21/14 12:02:31 PM
#871   Now over 5 years into the rally off davidc2 04/19/14 08:25:42 AM
#870   I like GALT a great deal and as 123tom 04/19/14 05:32:03 AM
#869   I'm holding too. I bought a tiny bit Darwinian 04/18/14 11:40:41 PM
#868   I submit to you that all serious and pugdaddy 04/18/14 09:40:58 PM
#867   What the Hell is going on? Games or Darwinian 04/18/14 07:37:01 PM
#866   Sorry,I cant address your specific question. 123tom 04/17/14 02:33:20 PM
#865   LOL! But that would be so sweet... thefamilyman 04/17/14 02:16:09 PM
#864   Anyone else see 60 volume on the april poonch1ne 04/17/14 01:31:37 PM
#863   lol. you guys are great 123tom 04/17/14 04:50:31 AM
#862   sheesh you are correct I completely forgot . bradfor123 04/17/14 01:09:15 AM
#861   You do realize that you asked this same thefamilyman 04/17/14 12:15:56 AM
#860   Disappointed in this I understand biotech is down bradfor123 04/16/14 11:36:02 PM
#859   11.00-10.80 resistance is winning today 123tom 04/16/14 03:12:55 PM
#858   ...So today "bottomed" at 10.56 123tom 04/14/14 04:31:24 PM
#857   This is why I Don't "throw away " 123tom 04/14/14 02:25:39 PM
#856   Galectin have a advantage right now I believe bradfor123 04/13/14 08:08:22 PM
#855   nice read I agree what better news could bradfor123 04/13/14 12:31:30 AM
#854   Technicals vs Fundamentals. You can throw both Chess Master 04/12/14 11:18:32 PM
#853   Same BS... different day...Ah, publicity. zest 04/12/14 03:52:31 PM
#852   Tesla, I agree with you about fundamentals and 123tom 04/11/14 11:19:18 PM
#851   I agree I mean really if as 1st bradfor123 04/11/14 08:40:03 PM
#850   Tom, My two cents -- I really Tesla1 04/11/14 07:01:22 PM
#849   the technical comment from 4 days ago, might 123tom 04/11/14 01:01:24 PM
#848   yes, getting a feeling for the tempo... 123tom 04/10/14 02:32:16 AM